Eligibility for hematopoietic stem cell transplantation in a cohort of children with sickle cell disease: a single-center report
Abstract Background Hematopoietic stem cell transplantation (HSCT), is the only currently available curative option for SCD. Yet, the eligibility of SCD patients for HSCT is always limited by the significant associated toxicity and lack of suitable donors. At Cairo University’s pediatric hematology...
| المؤلفون الرئيسيون: | , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
SpringerOpen
2024-02-01
|
| سلاسل: | Egyptian Pediatric Association Gazette |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1186/s43054-024-00247-5 |